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Abstract 
Beta-thalassaemia major is an autosomal recessive disorder that results in severe microcytic, hypochromic, 
haemolytic anemia among affected patients. Beta-thalassaemia has emerged as one of the most common public 
health problems in Indonesia, particularly among Riau Malays. This study aimed to observe the spectrum of 
mutations found in Riau Malay beta-thalassaemia major patients who attended the Thalassaemia Center, Arifin 
Achmad Hospital University Riau Pekanbaru, Indonesia. This was a cross-sectional study conducted with 68 
Riau Malay beta- thalassaemia major patients. DNA was extracted from the blood collected from the patients 
and subjected to polymerase chain reaction (PCR) amplification. Pcr product to sequens for the detection of 
mutations. The results revealed four mutations in the HBB at Riau Malay beta- thalassaemia patients; IVS-1 nt5 
(G > C), codon 26/HbE (G > A), IVS-1 nt1 (G > T), IVS-1 nt2 (T> C ) the two most common mutations 
observed were codon 26 (G >A) and IVS-1 nt5 (G > C). Four  Riau Malay patients in the present study, 
however, did not show any mutation in studied. 
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1. Introduction 
The thalassaemias are a group of anemia that results from a genetic defect which reduces the rate of synthesis of 
normal globin chains.  
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The thalassaemias are among the most common genetic disorders worldwide, occurring frequently in the Indian 
subcontinent, Southeast Asia and West Africa [1].  Recently, Beta-thalassaemia (BT) has emerged as one of the 
most common public health problems in Indonesia, particularly among Riau Malays.Thalassaemia is classified 
according to the chain of the globin molecule that is affected [2]. BT major is an autosomal recessive disorder 
that results in severe microcytic, hypochromic, haemolytic anemia among affected patients. BT is known to 
occur due to the mutations in the beta-globin gene (HBB) on chromosome 11 [3]. To date, there are over 200 
known mutations in HBB found to be associated with thalassaemia, but it is believed that each population has its 
own spectrum of mutations [5]. However, this study focused on BT mutations which are believed to occur 
commonly among the Riau Malay ethnic group. This study aimed to observe the spectrum of mutations found in 
BT major patients who attended the Thalassaemia Center Arifin Achmad  Hospital University Riau Indonesia. 
Our results added to the existing data on the most common mutations of HBB existing among the Malay ethnic 
group in Riau. 
2. Material and methods  
This was a cross-sectional study and was approved by Research and Ethics Committee, School of Medical 
Sciences, University Riau Indonesia, 68 Riau Malay patients diagnosed to have BT major and requiring a 
regular blood transfusion were included in this study. Informed consent was obtained from their parents prior to 
blood collection. All patients were interviewed to complete a questionnaire. Blood samples were later send to 
laboratories Biomedical, University of Andalas Padang Indonesia, for molecular analysis.  
DNA was extracted from the blood using a commercially-available DNA extraction kit, Nitrogen Pure link 
Genomic DNA Mini Kit . Polymerase chain reactions (PCR) with  sets of primers were used to amplify the exon  
and intron  of HBB that created a recognition site of mutation. Primer Forward HBB F sequens  5’- 
GGTACGGCTGTCATCACTTA-3’ with 20 bp and Primer Reserve  HBB  R  sequens 5’-
CCCCTTCCTATGACATGAAT-3 with length 21 bp.  Primers were desained with software bioinformatics 
Geneious and sentetised by Integrated DNA Technologies, Singapore. The reaction mixture for PCR 
amplification consisted of  Go Tag Green Master mix PCR, Promega  12,5 μL, Primer F 10 μL , Primer R 10  
μL, 25 mM MgCl2  2 μL , ddH2O 4μL, sample DNA 4 μL and a final volume of 25Μl [6]. 
 The PCR conditions were as follows: 95°C of pre- denaturation for 10 mins, 95°C of denaturation for 45 s, 
annealing at 66°C  for 1 min and 68°C of extension (1 min 30 s) for 35 cycles, followed by 68°C of final 
extension for 5 mins. In the C1000 TM Thermal Cycler Single Block Bio-Rad (USA) [7]. Amp icons were then 
detected by gel electrophoresis in a 1.5 % agarose gel and visualized  by GeldocBiorad. Subsequently, the PCR 
product that was obtained from the PCR amplification sends to Macrogen,Inc Seoul Korea for sequencing 
3. Results 
PCR amplification successfully generated 697 bp (Fig. 1) 




Figure 1: Product of PCR 697 bp. 
Amplicon was used for the detection mutation  with sequencing. The results revealed four mutations in the HBB 
in Riau Malay BT patients; IVS-1 nt5 (G > C), codon 26/HbE (G > A), IVS-1 nt1 (G > T), IVS-1 nt2 (T> C ). 
The two most common mutations observed were codon 26 (G >A) and IVS-1 nt5 (G > C). The mutation at 
codon 26/HbE (G > A) was observed in 43 patients, and other mutation IVS- 1 nt5 (G > C) was observed in 
48patients. The remaining mutations, IVS-1 nt1 (G > T) 5 patients,IVS-1 nt2 (T> C) 5 patients. The allele 
frequencies of mutant allele for the four mutations detected are shown in Table 1. Four Riau Malay patients in 
the present study, however, did not show any mutation in studied.  
Table 1: Polymorphism of β-gene Globin 
Type of mutations Allele f % 
IVS 1 nt5 (GC) CC (homozygote) 8 11,77 
 GC(heterozygote) 40 58,82 
 GG(wild type) 20 29,41 
    
Cd 26 (GAGAAG)glu-lys AA(homozygote) 2 2,94 
 GA(heterozygote) 41 60,29 
 GG(wild type) 25 36,76 
    
IVS 1 nt2 (TC) CC(homozygote) 0 0 
 TC(heterozygote) 5 7,35 
 TT(wild type) 63 92,65 
    
IVS 1 nt1(GT) TT(homozygote) 0 0 
 GT(heterozygote) 5 7,35 
 GG(wild type) 63 92,65 
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BT major is one of the most common single gene disorders in the multiracial population in Indonesia. The 
heterozygous carriers of BT in Indonesia are about 3-10% among the populations [8],  and have clearly emerged 
as one of the most common public health problems in Indonesia The World Health Organization has highlighted 
the importance of characterization of the spectrum of BT mutations as one of the ways for community control of 
BT [9], thus, characterization of the patients in this study is essential for the patient management in this country. 
This study has enriched the current database. Six common mutations have been identified among individuals 
originating from  East  Java, Indonesia, viz. codon 26/HbE (G > A)47,0%, IVS1-nt5 (G > C) 20,6%, codon 35 (- 
C) 17,6%,   codon 41–42 (4 bp del) 2,9%, codon 15 (- T) 5,9 %, IVSII-654 (C> T) 2,9 %, [10]. The most 
common mutation among Malays, followed by IVS1- nt5 (G > C) 43.1 %, 17.0% respectively [11]. Reported in 
several studies, revealed that mutation results in  IVS-I-5 (G > C) 43.5%, codon 26 /Hb E(G > A) 28.2%, IVS-I-
1 (G > A) 5.0%, codon 15 (TGG > TAG) 3.8%, IVS-I-1 (G > T) 3.1% [12]. Hb E is hemoglobin variants which 
are common in South East Asia.  These Hb variants result from amino acid changes at amino acid 26 
(glutamate→lysine) these single base substitutions also create an alternate splicing site leading to decreased 
production of the β-globin chain [13]. IVS1- nt5 (G > C, a large portion of all beta-thalassemic mutations. These 
mutations affect the splicing process at variable degree, depending on the position in which the mutation occurs 
[14]. Mutations that affect either of the invariant dinucleotide at the intron-exon junction (the GT motif at the 5' 
or donor site and the AG motif at the 3' or acceptor site) completely abolish normal splicing and result in beta- + 
thalassaemia. Mutations occurring in the splicing consensus sequences are instead of beta type, resulting in 
variable degrees of defective splicing and causing milder types of beta- thalassaemia. Other mutations occurring 
in exon or intron sequences may activate a cryptic splicing site, thus leading to abnormal mRNA processing. 
Even in these cases defective splicing occurs at variable degrees, resulting in phenotypes that range from mild to 
severe [15], The molecular characterization of BT mutations can be considered as a stepping stone in identifying 
the spectrum of mutations in a population. The results from this study add to the existing data on the spectrum of 
BT mutations among Riau Malay patients, although a larger number of patients would provide a more accurate 
representation of the spectrum of mutations.  
4. Conclusion 
Our results added to the existing data on the common characterization of BT mutations in Riau Malays will help 
the establishment of a rapid and effective prenatal diagnosis programme, or genetic counselling in this ethnic 
group in Riau Malay beta-thalassaemia patients.  
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